Atlas Trials

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

Clinical trial NCT00916747 · UNKNOWN

Trial details

NCT number
NCT00916747
Sponsor
Boston Children's Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Progeria
Start date
2009-08-01
Primary completion
2022-02-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.